ResearcherSecond Military Medical UniversityNo recent work listed
Lu Zhuang
Matched on OpenAlex author ID A5108713964. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper
Papers 4
- Silencing GS Homeobox 2 Alleviates Gemcitabine Resistance in Pancreatic Cancer Cells by Activating SHH/GLI1 Signaling Pathway. Co-author DOI 10.1007/s10620-021-07262-1↗
- Downregulation of GSTM2 enhances gemcitabine chemosensitivity of pancreatic cancer in vitro and in vivo. First author DOI 10.1016/j.pan.2020.12.008↗
- miR-205 targets runt-related transcription factor 2 to inhibit human pancreatic cancer progression. Co-author DOI 10.3892/ol.2018.9689↗
- HPP1 gene promoter methylation in pancreatic cancer: correlation with carcinogenesis and clinical implication. First author PMID 31949740↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lisi Peng · 3 shared papers, 2018–2022 · strength 0.35
- Paper Silencing GS Homeobox 2 Alleviates Gemcitabine Resistance in Pancreatic Cancer Cells by Activating SHH/GLI1 Signaling P… DOI 10.1007/s10620-021-07262-1↗
- Paper Downregulation of GSTM2 enhances gemcitabine chemosensitivity of pancreatic cancer in vitro and in vivo. DOI 10.1016/j.pan.2020.12.008↗
- Paper HPP1 gene promoter methylation in pancreatic cancer: correlation with carcinogenesis and clinical implication. PMID 31949740↗
- Yang Zhang · 2 shared papers, 2018–2022 · strength 0.24
- Kun Lin · 2 shared papers, 2018–2022 · strength 0.24
- Zhaoshen Li · 2 shared papers, 2018–2021 · strength 0.20
- Zhao‐Shen Li · 1 shared paper, 2019 · strength 0.14
- Thiruvengadam Arumugam · 1 shared paper, 2021 · strength 0.11
- Haojie Huang · 1 shared paper, 2021 · strength 0.11
- Hui Jiang · 1 shared paper, 2021 · strength 0.11
- Baoan Ji · 1 shared paper, 2021 · strength 0.11
- Craig D. Logsdon · 1 shared paper, 2021 · strength 0.11
- Kaixuan Wang · 1 shared paper, 2018 · strength 0.08
- Haojie Huang · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.